article thumbnail

How AI will reshape pharma by 2025

Drug Target Review

Looking ahead, 2025 could represent a major turning point for the pharmaceutical sector. In 2025, I think well see breakthroughs that allow us to make significant advances in rare diseases, where the data is small. While current breakthroughs are impressive, Smith anticipates even greater advancements by 2025.

article thumbnail

CDD Vault Update (June #2 2025): Bulk Register Sequences with Custom Monomers, Set X-axis Ranges in Plots, Filter AI Bioisostere Suggestions, Inventory Debits from ELN

Collaborative Drug

CDD Vault Update (June #2 2025): Bulk Register Sequences with Custom Monomers, Set X-axis Ranges in Plots, Filter AI Bioisostere Suggestions, Inventory Debits from ELN

179
179
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

June Q2 2025 - Product Update Webinar: AI+ and Curves

Collaborative Drug

Explore new AI+ and curve fitting tools in CDD Vault for structure prediction, docking, and assay analysis. Now available with no setup required.

article thumbnail

New Antibody Shot, Enflonsia, Could Help Protect Babies From RSV

Drugs.com

THURSDAY, June 12, 2025 — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. Food and Drug Administration (FDA) has approved a monoclonal.

Virus 289
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

📆 May 14th, 2025 at 9:30 AM PDT, 12:30 PM EDT, 5:30 PM BST Navigating the AI Landscape 🤖 Explore the opportunities and challenges with integrating AI in healthcare and disease prevention. Register today to save your seat!

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Drugs.com

WEDNESDAY, June 11, 2025 -- The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.The combination pill is the first and only FDA-approved triple combination.

article thumbnail

From Transgender Care To Vaping: Key Takeaways From SCOTUS 2025 Term

Drugs.com

FRIDAY, June 27, 2025 — From allowing states to ban gender-transition care and sales of flavored vapes to minors to rolling back the landmark Clean Air Act, the U.S. Supreme Court had a consequential term. The Washington Post cites these as.

214
214